These data came up today in the GSK presentation and the cc. They confirmed interferon does not add significant efficacy to Bepirovirsen monotherapy They are hoping adding the JNJ siRNA drug will increase efficacy or at least bring more patients into the low surface antigen range to enable more patients to be eligible for Bepi